Scale and capacity Nephron operates a large 840,000 sq ft campus with high-volume sterile manufacturing capabilities, including blow-fill-seal and aseptic platforms and batch sizes up to 9,000 liters, indicating strong capacity for contract manufacturing, large-quantity sterile products, and potential for scalable partnerships.

Outsourcing footprint With a 503B Outsourcing Facility and support across development to commercial supply, Nephron presents a compelling partner for customers seeking compliant, end-to-end manufacturing solutions, device-ready sterile products, and distribution partnerships.

Investments in capacity Recent multi-million dollar investments in BFS capacity and InjectEZ syringe manufacturing signal a growth trajectory and readiness to onboard new programs, especially those requiring sophisticated sterile fill/finish and specialty packaging.

Financial momentum Revenue in the multi-billion-dollar range and major institutional funding from prominent investors suggest strong financial backing and potential for long-term manufacturing partnerships, licensing deals, and co-development opportunities.

Strategic partnerships Past collaborations in ketamine formulation and other inhalation solutions, along with a readiness to support licensing, international distribution, and technology transfer, position Nephron as a versatile partner for pharma companies seeking scalable sterile product solutions.